Investors will have to either approach the foreign investment promotion board (FIPB) for approvals or wait till the changes are notified.

FDI policy provides for 100 per cent FDI under automatic route in greenfield pharma and upto 100 per cent under government route in brownfi...

"The pharma industry is growing by 14 per cent every year. With relaxed FDI norms, I think pharma sector will grow by 20 per cent," Kumar s...

The government today allowed up to 74 per cent foreign direct investment in the existing pharmaceutical companies through automatic route.

According to a proposal, FDI up to 49% should be allowed through the automatic route and anything beyond through approval of the FIPB, sour...

The experts would look into the impact of foreign direct investment in the brownfield pharmaceutical companies and access to affordable med...

India is now keen on drawing investments into the pharmaceuticals segment to reduce dependence on China for bulk drugs.

We must first assess the need of the pharma sector and then evaluate whether mere change of ownership would meet its needs.

The Union Cabinet has rejected a proposal to limit foreign direct investment in domestic manufacturers of “rare and critical” drugs.

Currently, 100 per cent FDI is permitted in brownfield pharma firms through clearance from the Foreign Investment Promotion Board (FIPB).

Arun Maira launched a broadside against the FIPB, criticising the process by which it approves overseas investment proposals as being opaqu...

Chidambaram today said the government will soon finalise the foreign investment policy on brownfield pharmaceutical projects.

DIPP will soon move a note in consultation with the health ministry, department of pharmaceuticals and the finance ministry creating a new ...

Commerce Minister Anand Sharma has urged Prime Minister Manmohan Singh to convene a high-level review meeting to deliberate on the matter.

Govt said a total of eight proposals amounting to Rs 1,842.55 cr relating to FDI in brownfield pharma sector were approved in August this y...

DIPP may consider allowing foreign direct investment of up to 49 per cent through automatic route in existing Indian pharmaceutical firms.

An inter-ministerial group set up by the finance ministry to consider new norms for clearing FDI proposals in pharmaceutical sector.